147 related articles for article (PubMed ID: 6145770)
21. Opiate agonists and antagonists discriminated by receptor binding in brain.
Pert CB; Pasternak G; Snyder SH
Science; 1973 Dec; 182(4119):1359-61. PubMed ID: 4128222
[TBL] [Abstract][Full Text] [Related]
22. Homobenzomorphan compounds with a potent narcotic antagonist property.
Nurimoto S; Suzuki S; Hayashi G; Takeda M
Jpn J Pharmacol; 1974 Jun; 24(3):461-9. PubMed ID: 4449151
[No Abstract] [Full Text] [Related]
23. Central and peripheral inhibition of gastrointestinal transit in rats: narcotics differ substantially by acting at either or both levels.
Peracchia F; Bianchi G; Fiocchi R; Petrillo P; Tavani A; Manara L
J Pharm Pharmacol; 1984 Oct; 36(10):699-701. PubMed ID: 6150093
[TBL] [Abstract][Full Text] [Related]
24. Differences in the morphine-induced inhibition of small and large intestinal transit: Involvement of central and peripheral μ-opioid receptors in mice.
Matsumoto K; Umemoto H; Mori T; Akatsu R; Saito S; Tashima K; Shibasaki M; Kato S; Suzuki T; Horie S
Eur J Pharmacol; 2016 Jan; 771():220-8. PubMed ID: 26712376
[TBL] [Abstract][Full Text] [Related]
25. Effect of intracerebroventricular administration of morphine upon intestinal motility in rat and its antagonism with naloxone.
Parolaro D; Sala M; Gori E
Eur J Pharmacol; 1977 Dec; 46(4):329-38. PubMed ID: 590342
[TBL] [Abstract][Full Text] [Related]
26. Oxilorphan (l-N-cyclopropylmethyl-3,14-dihydroxymorphinan): a new synthetic narcotic antagonist.
Pircio AW; Gylys JA
J Pharmacol Exp Ther; 1975 Apr; 193(1):23-34. PubMed ID: 237112
[TBL] [Abstract][Full Text] [Related]
27. Antidiarrheal and central nervous system activities of SC-27166 (2-[3 - 5 - methyl - 1, 3, 4 - oxadiazol - 2 - yl) - 3, 3 - diphenylpropyl] - 2 - azabicyclo [2.2.2]octane), a new antidiarrheal agent, resulting from binding to opiate receptor sites of brain and myenteric plexus.
Mackerer CR; Brougham LR; East PF; Bloss JL; Dajani EZ; Clay GA
J Pharmacol Exp Ther; 1977 Dec; 203(3):527-38. PubMed ID: 200732
[TBL] [Abstract][Full Text] [Related]
28. Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats.
Gmerek DE; Cowan A; Woods JH
J Pharmacol Exp Ther; 1986 Jan; 236(1):8-13. PubMed ID: 3941402
[TBL] [Abstract][Full Text] [Related]
29. Centrally and peripherally mediated inhibition of intestinal motility by opioids.
Schulz R; Wüster M; Herz A
Naunyn Schmiedebergs Arch Pharmacol; 1979 Sep; 308(3):255-60. PubMed ID: 503253
[TBL] [Abstract][Full Text] [Related]
30. Evidence for serotonergic system involvement in the effect of morphine on gastrointestinal motility in the rat.
Pourgholami MH; Goshadrou F
Gen Pharmacol; 1995 Jul; 26(4):779-83. PubMed ID: 7635252
[TBL] [Abstract][Full Text] [Related]
31. Social conflict analgesia: studies on naloxone antagonism and morphine cross-tolerance in male DBA/2 mice.
Rodgers RJ; Randall JI
Pharmacol Biochem Behav; 1985 Nov; 23(5):883-7. PubMed ID: 2417263
[TBL] [Abstract][Full Text] [Related]
32. Central effect of SNC 80, a selective and systemically active delta-opioid receptor agonist, on gastrointestinal propulsion in the mouse.
Broccardo M; Improta G; Tabacco A
Eur J Pharmacol; 1998 Jan; 342(2-3):247-51. PubMed ID: 9548393
[TBL] [Abstract][Full Text] [Related]
33. Modification of the analgesic action of pethidine and morphine by three opiate antagonists, a respiratory stimulant (doxapram) and an analeptic (nikethamide); a study using an experimental pain stimulus in man.
Dundee JW; Gupta PK; Jones CJ
Br J Pharmacol; 1973 Jun; 48(2):326P. PubMed ID: 4733735
[No Abstract] [Full Text] [Related]
34. Antagonism of opiate mydriasis in mice.
Korczyn AD; Rock M
Br J Pharmacol; 1981 Aug; 73(4):807-10. PubMed ID: 7272583
[TBL] [Abstract][Full Text] [Related]
35. Buprenorphine: high-affinity binding to dorsal spinal cord.
Villiger JW; Taylor KM
J Neurochem; 1982 Jun; 38(6):1771-3. PubMed ID: 6281389
[TBL] [Abstract][Full Text] [Related]
36. Antinociceptive actions of morphine and buprenorphine given intrathecally in the conscious rat.
Bryant RM; Olley JE; Tyers MB
Br J Pharmacol; 1983 Apr; 78(4):659-63. PubMed ID: 6687818
[TBL] [Abstract][Full Text] [Related]
37. Interactions of reserpine and morphine on rat intestinal transit.
Stewart JJ
J Pharmacol Exp Ther; 1981 Mar; 216(3):521-5. PubMed ID: 7205632
[TBL] [Abstract][Full Text] [Related]
38. Levallorphan and related compounds.
Leimgruber W; Mohacsi E; Baruth H; Randall LO
Adv Biochem Psychopharmacol; 1973; 8(0):45-50. PubMed ID: 4794970
[No Abstract] [Full Text] [Related]
39. Blocking of enhanced sensitivity to behavioral effects of naloxone induced by narcotic agonists in rats.
Jain R; Ray R
Indian J Physiol Pharmacol; 2003 Oct; 47(4):407-14. PubMed ID: 15266952
[TBL] [Abstract][Full Text] [Related]
40. Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone.
Shannon HE; Cone EJ; Gorodetzky CW
J Pharmacol Exp Ther; 1984 Jun; 229(3):768-74. PubMed ID: 6547177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
